Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Streptococcus pneumoniae is a leading cause of pneumonia and meningitis worldwide. Many different serotypes co-circulate endemically in any one location1,2. The extent and mechanisms of spread and vaccine-driven changes in fitness and antimicrobial resistance remain largely unquantified. Here using geolocated genome sequences from South Africa (n = 6,910, collected from 2000 to 2014), we developed models to reconstruct spread, pairing detailed human mobility data and genomic data. Separately, we estimated the population-level changes in fitness of strains that are included (vaccine type (VT)) and not included (non-vaccine type (NVT)) in pneumococcal conjugate vaccines, first implemented in South Africa in 2009. Differences in strain fitness between those that are and are not resistant to penicillin were also evaluated. We found that pneumococci only become homogenously mixed across South Africa after 50 years of transmission, with the slow spread driven by the focal nature of human mobility. Furthermore, in the years following vaccine implementation, the relative fitness of NVT compared with VT strains increased (relative risk of 1.68; 95% confidence interval of 1.59-1.77), with an increasing proportion of these NVT strains becoming resistant to penicillin. Our findings point to highly entrenched, slow transmission and indicate that initial vaccine-linked decreases in antimicrobial resistance may be transient.

Original publication

DOI

10.1038/s41586-024-07626-3

Type

Journal

Nature

Publication Date

07/2024

Volume

631

Pages

386 - 392

Addresses

Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK. sophie.belman@sanger.ac.uk.

Keywords

Global Pneumococcal Sequencing Consortium, Humans, Streptococcus pneumoniae, Pneumococcal Infections, Penicillins, Pneumococcal Vaccines, Vaccines, Conjugate, Penicillin Resistance, Locomotion, Genome, Bacterial, South Africa, Genetic Fitness, Geographic Mapping, Serogroup, Heptavalent Pneumococcal Conjugate Vaccine